AI-powered insights from 8-K, 6-K, 10-K and 10-Q filings with category and key takeaways
Total
0
10-K
0
10-Q
0
8-K
0
6-K
0
13F
0
Other
0
Showing 30 of 16187 summaries
Filing ID: 786794 • Mar 25, 2026, 9:10 AM ET
Stockholders approved increase in authorized common shares from 200,000,000 to 300,000,000
Authorized 30,000,000 shares of blank check preferred stock
98.44% of votes cast (102,017,284 shares) in favor; 1.55% against
SafeSpace Global Corporation stockholders approved via consent solicitation an amendment to its Certificate of Incorporation, increasing authorized common stock from 200,000,000 to 300,000,000 shares and authorizing 30,000,000 shares of blank check preferred stock. The approval enhances capital capacity for growth initiatives amid potential dilution risks.
Filing ID: 786793 • Mar 25, 2026, 9:10 AM ET
Tower to acquire full ownership of TPSCo's 300mm Fab 7 (Uozu) under a new wholly-owned Japanese subsidiary.
NTCJ (Nuvoton) to acquire full ownership of 200mm Fab 5.
Transaction targeted to close on April 1, 2027, subject to customary conditions and regulatory approvals.
Tower Semiconductor announced a strategic restructuring of its Japan operations under TPSCo, taking full ownership of the 300mm Fab 7 facility while Nuvoton's NTCJ takes full ownership of the 200mm Fab 5, supported by mutual long-term supply agreements. The company plans to expand 300mm capacity up to four times current levels, contingent on METI subsidy approval, to meet strong demand in photonics and optical platforms.
Filing ID: 786803 • Mar 25, 2026, 9:20 AM ET
Entered Purchase Agreement on 2026-03-25 with twenty Purchasers
Issuing 71,381,818 Common Stock shares at $1.10 per share
Pre-Funded Warrants for 71,381,818 shares at $1.099 per warrant, exercisable at $0.001 per share
Next Technology Holding Inc. entered into a securities purchase agreement on March 25, 2026, with twenty investors to issue and sell in a registered direct offering 71,381,818 shares of common stock at $1.10 per share and pre-funded warrants to purchase up to 71,381,818 shares at $1.099 per warrant, expecting approximately $157 million in gross proceeds for working capital.
Filing ID: 786802 • Mar 25, 2026, 9:20 AM ET
Clinical study evaluated enhanced EpiCapture™ on approximately 750 patient samples
Test delivers 85% AUC clinical accuracy
Enhanced algorithm integrates machine learning, DNA biomarkers, and patient ethnicity
Trinity Biotech plc announced successful clinical results for its enhanced EpiCapture™ prostate cancer test, achieving 85% AUC accuracy in a study of approximately 750 ethnically diverse patient samples using machine learning and patient ethnicity data. The company plans to commercialize the test as a Laboratory Developed Test through its New York reference laboratory, marking its entry into precision oncology diagnostics.
Filing ID: 786814 • Mar 25, 2026, 9:30 AM ET
Net loss of -$27.5M for FY 2025 transition period.
Total operating expenses reached $17.1M.
Digital assets valued at $86.6M on balance sheet.
USBC, Inc. reported a net loss of $27.5M for the fiscal year 2025 transition period ended December 31, 2025, compared to no prior year data provided in the filing. The loss was driven by a $17.1M operating loss from $17.1M total operating expenses, including $16.9M in selling, general, and administrative expenses and $254K in research and development. Other expenses netted -$26.1M, primarily a -$27.2M change in fair value of digital assets, partially offset by $1.1M other derivative income, $38K interest income, and a -$15.7M income tax benefit. No revenue was generated, reflecting the company's pre-revenue development stage focused on tokenized deposit offerings and Bitcoin treasury strategy. Balance sheet highlights include total assets of $93.7M, with $86.6M in digital assets and $6.8M current assets anchored by $4.1M cash. Stockholders' equity stood at $81.5M. Cash flows showed -$4.6M used in operations and a net -$4.7M decrease in cash. Forward-looking, USBC advances its USBC tokenized deposit pilot (Phase 1 initiated March 2026), partnerships with Uphold and Vast Bank, and Bitcoin yield generation via derivatives, positioning for future financial technology growth amid regulatory and market risks.
Filing ID: 786813 • Mar 25, 2026, 9:30 AM ET
Entered First Amendment on March 17, 2026, effective Amendment Effective Date
Consolidated Existing Notes ($2 million principal) and Additional Notes ($200,000 principal) into $2.2 million aggregate principal Amended and Restated Notes
Maturity date: earlier of March 26, 2026 or Event of Default
On March 17, 2026, OneMeta Inc. entered into a First Amendment to its October 31, 2025 Note and Warrant Purchase Agreement, consolidating $2 million Existing Notes and $200,000 Additional Notes into $2.2 million Amended and Restated Secured Convertible Promissory Notes maturing March 26, 2026. The amendment includes conversion options into common or preferred stock, 14% interest rate, subordination covenants, and most-favored-nation rights, impacting near-term liquidity and potential dilution.
Filing ID: 786800 • Mar 25, 2026, 9:20 AM ET
2.0% NSR royalty on Shea Creek project deposits (Kianna, Anne, Colette, 58B)
Shea Creek indicated resources: 67.57 million lbs U3O8 (2,056,000 tonnes at 1.49% U3O8)
Shea Creek inferred resources: 28.06 million lbs U3O8 (1,254,000 tonnes at 1.02% U3O8)
Fusion Fuel Green PLC highlighted Royal Uranium Inc.'s anticipated 2.0% Net Smelter Return royalty on the Shea Creek uranium project, featuring 67.57 million lbs indicated and 28.06 million lbs inferred U3O8 resources operated by Orano Canada Inc. and Uranium Energy Corp. This is part of a 16-royalty portfolio to be acquired via the previously announced share exchange agreement.
Filing ID: 786812 • Mar 25, 2026, 9:30 AM ET
Initiated strategic alternatives review on March 25, 2026, including potential mergers, investments, or sale of the Company
Reduced number of employees on March 19, 2026, to reduce cash expenditures
Expects $51,000 pre-tax cash charges for severance payments to former employees in Q1 2026
ENDRA Life Sciences Inc. initiated a process to evaluate strategic alternatives, including mergers, asset sales, or business combinations, to maximize shareholder value, and engaged Lucid Capital Management and K&L Gates. On March 19, 2026, it reduced employees, expecting approximately $51,000 in pre-tax cash severance charges in Q1 2026 to extend its operational runway.
Filing ID: 786811 • Mar 25, 2026, 9:30 AM ET
Granted 785,356 RSUs on March 25, 2026: 157,000 each to Dr. Yifan Li, Dr. Kai Sun, Mr. Shaoqing Xiang; 6,565 to Dr. Hui Wang; 307,791 to 70 employees.
Director RSUs to Dr. Li, Dr. Sun, Mr. Xiang vest over 48 months in four equal portions; Dr. Wang's vest over three years in three portions.
No performance targets for grants; subject to clawback and forfeiture provisions.
Hesai Group granted 785,356 RSUs representing Class B Ordinary Shares to four directors and 70 employees on March 25, 2026, under the 2021 Plan to incentivize performance, retain talent, and align interests with shareholders. The company entered a Supply of Products Framework Agreement with connected person Sharpa to supply LiDAR products and robotic actuators from March 25 to December 31, 2026, with an annual cap of RMB100 million.
Filing ID: 786807 • Mar 25, 2026, 9:30 AM ET
Q4 total net revenues RMB3,172.2 million, +5.9% from RMB2,994.4 million same quarter 2024
Q4 GAAP income from operations RMB175.5 million, +139.8% from RMB73.2 million same quarter 2024, operating margin 5.5%
FY total net revenues RMB9,945.5 million, +5.6% from RMB9,422.2 million FY2024
Baozun Inc. announced unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025, with Q4 total net revenues of RMB3,172.2 million, up 5.9% year-over-year, and FY total net revenues of RMB9,945.5 million, up 5.6% year-over-year. Profitability improved significantly, including Q4 GAAP income from operations of RMB175.5 million, up 139.8% year-over-year, and positive FY GAAP operating income of RMB56.6 million.
Filing ID: 786805 • Mar 25, 2026, 9:30 AM ET
Q4 2025 net operating revenue RMB1,411.2 million (US$201.8 million), +105.5% YoY
Q4 2025 insurance-related income RMB1,310.4 million (US$187.4 million), +125.0% YoY
Q4 2025 operating profit RMB83.9 million (US$12.0 million), +58.4% YoY
Waterdrop Inc. announced unaudited financial results for Q4 and FY 2025, with Q4 net operating revenue of US$201.8 million up 105.5% year-over-year and net profit attributable to ordinary shareholders of US$23.2 million. The company declared a cash dividend of approximately US$10.8 million and reported cumulative repurchases of 60.7 million ADSs for US$118.1 million as of end of February 2026.
Filing ID: 786806 • Mar 25, 2026, 9:30 AM ET
Total net revenues RMB9,945.5 million (US$1,422.2 million), increase of 5.6% year-over-year
Service revenues RMB6,095.9 million (US$871.7 million), increase of 2.4% year-over-year
Income from operations RMB56.6 million (US$8.1 million) versus loss of RMB114.8 million in 2024
Baozun Inc. announced unaudited consolidated annual results for the year ended December 31, 2025, with total net revenues of RMB9,945.5 million (US$1,422.2 million), up 5.6% year-over-year, and income from operations of RMB56.6 million (US$8.1 million) versus a loss of RMB114.8 million in 2024. Non-GAAP net income attributable to ordinary shareholders was RMB44.2 million (US$6.3 million).
Filing ID: 786809 • Mar 25, 2026, 9:30 AM ET
Event Type: Regulation FD Disclosure - Investor Presentation (Items: 7.01)
Mativ Holdings, Inc. furnished an investor presentation under Item 7.01 providing an overview of trailing twelve-month financials, segment breakdowns, post-merger transformation progress including $65M+ synergies and facility reductions from 48 to 34, and planned capacity investments. This disclosure offers investors insights into current performance and strategic priorities.
Filing ID: 786808 • Mar 25, 2026, 9:30 AM ET
ITEM 3: D 'Risk factors' from 2025 Annual Report on Form 20-F
Registered in England & Wales No. 3888792
Registered Office: 79 New Oxford Street London WC1A 1DG
GSK plc filed a Form 6-K on 2026-03-25 referencing ITEM 3: D 'Risk factors' in its Annual Report on Form 20-F for 2025. The filing includes the company's registration in England & Wales No. 3888792 and registered office at 79 New Oxford Street London WC1A 1DG.
Filing ID: 786808 • Mar 25, 2026, 9:30 AM ET
ITEM 3: D 'Risk factors' from 2025 Annual Report on Form 20-F
Registered in England & Wales No. 3888792
Registered Office: 79 New Oxford Street London WC1A 1DG
GSK plc filed a Form 6-K on 2026-03-25 referencing ITEM 3: D 'Risk factors' in its Annual Report on Form 20-F for 2025. The filing includes the company's registration in England & Wales No. 3888792 and registered office at 79 New Oxford Street London WC1A 1DG.
Filing ID: 786804 • Mar 25, 2026, 9:30 AM ET
Board meeting concluded March 24, 2026, discussing USO letter titled 'Request for Dr. Ricardo Roa Barragán to Be Removed from His Position as President of Ecopetrol'
Attorney General charges against President disclosed March 11, 2026
No breaches of credit agreements or material contracts as of March 25, 2026
Ecopetrol S.A.'s Board of Directors, after meeting on March 24, 2026, addressed USO union's request, minority shareholders' queries, and an attorney's demand for President Ricardo Roa Barragán's removal amid formal charges by Colombia's Attorney General. The Board confirmed no regulatory violations, contract breaches, or securities authority notifications, with ongoing risk monitoring.
Filing ID: 786815 • Mar 25, 2026, 9:40 AM ET
SPA Amendment allocates equity offering net proceeds: until $751,220.76 paid to Advisors (A.G.P./Alliance Global Partners and Curvature Securities LLC), 20% to fees, 40% to Note Purchased Crypto, 40% to corporate purposes.
Post-fee payment: 50% of equity proceeds to Note Purchased Crypto, 50% to corporate purposes including $77,000 additional Advisor fees due no earlier than December 31, 2026.
Company to reimburse Buyers and Advisors up to $65,000 in costs/legal fees from equity proceeds.
La Rosa Holdings Corp. entered into an Amendment to its Securities Purchase Agreement (SPA) and an Amendment to the Token Right on March 24, 2026, with ATW AI Infrastructure III LLC and ATW AI Infrastructure IIIB LLC. The amendments detail allocation of net proceeds from equity offerings to advisor fees, Note Purchased Crypto acquisitions as treasury assets, and general corporate purposes including AI data center development, impacting capital deployment strategy.
Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET
Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.
Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.
Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.
Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.
Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET
Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.
Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.
Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.
Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.
Filing ID: 786817 • Mar 25, 2026, 10:00 AM ET
Aegon nominated Marco Keim to a.s.r. Supervisory Board to succeed Lard Friese.
Lard Friese stepping down following December 10, 2025 announcement to focus on Aegon relocation.
Vote at a.s.r. AGM on May 20, 2026; term to July 4, 2028 if approved.
Aegon Ltd nominated Marco Keim, CEO of its International business and Executive Committee member, to succeed Lard Friese as non-independent member on the Supervisory Board of a.s.r., where Aegon holds a strategic 24% stake. The proposal will be voted on at a.s.r.'s AGM on May 20, 2026; if approved, Keim's term runs until July 4, 2028.
Filing ID: 786816 • Mar 25, 2026, 9:50 AM ET
Amendment completed March 20, 2026 to Credit Agreement with U.S. Bank National Association as Administrative Agent
Revolving credit facility reduced from $1.55 billion to $1.30 billion, maturity extended to March 20, 2031
Existing $114.3 million term loan maturity extended to March 20, 2031
On March 20, 2026, The Andersons, Inc. completed an amendment to its Credit Agreement dated January 11, 2019, reducing the revolving credit facility capacity from $1.55 billion to $1.30 billion, extending maturities on revolving and term facilities to 2031 and 2034, and consolidating term loans into a $256.4 million facility. This restructures the company's debt profile and extends liquidity access.
Filing ID: 786818 • Mar 25, 2026, 10:10 AM ET
Sony Honda Mobility discontinues development and launch of first model AFEELA1 and second model.
Honda and Sony to review SHM's future direction considering EV market changes.
Honda FY2026 consolidated operating profit forecast revised to -570,000 to -270,000 million yen from 550,000 million yen.
Honda Motor Co., Ltd. and Sony Group Corporation announced a review of Sony Honda Mobility Inc.'s business direction, including discontinuation of development and launch of AFEELA1 and its second model, due to Honda's EV strategy reassessment. Honda expects immaterial impact on its FY ending March 31, 2026 consolidated financial forecasts, previously revised downward on March 12, 2026, to reflect expected losses of 820.0-1,120.0 billion yen in operating costs and 110.0-150.0 billion yen in equity method losses.
Filing ID: 786818 • Mar 25, 2026, 10:10 AM ET
Sony Honda Mobility discontinues development and launch of first model AFEELA1 and second model.
Honda and Sony to review SHM's future direction considering EV market changes.
Honda FY2026 consolidated operating profit forecast revised to -570,000 to -270,000 million yen from 550,000 million yen.
Honda Motor Co., Ltd. and Sony Group Corporation announced a review of Sony Honda Mobility Inc.'s business direction, including discontinuation of development and launch of AFEELA1 and its second model, due to Honda's EV strategy reassessment. Honda expects immaterial impact on its FY ending March 31, 2026 consolidated financial forecasts, previously revised downward on March 12, 2026, to reflect expected losses of 820.0-1,120.0 billion yen in operating costs and 110.0-150.0 billion yen in equity method losses.
Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET
Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11
Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date
Trustee: The Bank of New York Mellon, London Branch
Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.
Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET
Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11
Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date
Trustee: The Bank of New York Mellon, London Branch
Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.
Filing ID: 786820 • Mar 25, 2026, 10:40 AM ET
Redemption of entire $1,000,000,000 principal of 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 (CUSIP: 53944YAP8, ISIN: US53944YAP88) on 2026-05-11
Redemption Price: 100% principal plus accrued interest to but excluding Redemption Date
Trustee: The Bank of New York Mellon, London Branch
Lloyds Banking Group plc announced the full redemption of its $1,000,000,000 1.627% Senior Callable Fixed-to-Fixed Rate Notes due 2027 on May 11, 2026, at 100% of principal plus accrued but unpaid interest. The NYSE listing of the Notes will be cancelled on or shortly after the Redemption Date, reducing outstanding debt.
Filing ID: 786823 • Mar 25, 2026, 11:00 AM ET
Morgan Higgins appointed as Director of MainStreet Bank on March 25, 2026.
Ms. Higgins is Partner at Blue Delta Capital Partners, leading equity investments in government contracting businesses.
Prior to Blue Delta, Ms. Higgins was Executive Director at JP Morgan Chase, focusing on aerospace and government services banking.
MainStreet Bancshares, Inc. issued a press release announcing the appointment of Morgan Higgins to MainStreet Bank's Board of Directors. Ms. Higgins brings over 20 years of experience in banking and government contracting, including roles at Blue Delta Capital Partners and JP Morgan Chase, to support the Bank's growth in defense and government services markets.
Filing ID: 786823 • Mar 25, 2026, 11:00 AM ET
Morgan Higgins appointed as Director of MainStreet Bank on March 25, 2026.
Ms. Higgins is Partner at Blue Delta Capital Partners, leading equity investments in government contracting businesses.
Prior to Blue Delta, Ms. Higgins was Executive Director at JP Morgan Chase, focusing on aerospace and government services banking.
MainStreet Bancshares, Inc. issued a press release announcing the appointment of Morgan Higgins to MainStreet Bank's Board of Directors. Ms. Higgins brings over 20 years of experience in banking and government contracting, including roles at Blue Delta Capital Partners and JP Morgan Chase, to support the Bank's growth in defense and government services markets.
Filing ID: 786821 • Mar 25, 2026, 10:50 AM ET
Filed Post-Effective Amendment No. 1 to Form S-11 (Reg. No. 333-290772) on March 12, 2026, including 2025 Form 10-K financials.
Executive officers include R. Ramin Kamfar (CEO, age 62), Jordan Ruddy (President, age 63), Ryan S. MacDonald (CIO, age 43).
Board of directors: R. Ramin Kamfar (Chairman/CEO), I. Bobby Majumder (Lead Independent), Elizabeth Harrison, Kamal Jafarnia, Romano Tio (all independent except Kamfar).
Bluerock Homes Trust, Inc. filed this Form 8-K under Item 8.01 to incorporate by reference into its Form S-11 Registration Statement (effective December 10, 2025) and upcoming 2026 Proxy Statement certain Part III disclosures, including executive officers, board of directors, governance, director compensation, security ownership, related party transactions, and accountant fees. This updates the Registration Statement with audited 2025 financials and provides investor transparency on governance and affiliations.
Filing ID: 786825 • Mar 25, 2026, 11:10 AM ET
Total shares repurchased: 70,793,900 shares
Total purchase amount: 249,999,854,281 yen
Recent repurchase (March 1-24, 2026): 33,585,600 shares for 112,944,325,662 yen
Sony Group Corporation announced the status and conclusion of its repurchase of common stock under board resolutions dated November 11, 2025, February 5, 2026, and February 26, 2026. As of March 24, 2026, Sony repurchased 70,793,900 shares for 249,999,854,281 yen via open market purchases on the Tokyo Stock Exchange.